Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Gladstone GAINN Stock Analysis Flat at 2513 Whats Next 20260518 What AH Realty AHRTs 092 Decline Means for Investors 20260517 KinderCare KLC Stock Up 129 Key Resistance at 414 20260519 Commerzbank Plans 3000 Job Cuts Amid UniCredit Takeover Defense Franklin Street Properties FSP Slides 33 as Office Real Estate Concerns Persist GAIL India Q4FY26 Results Net Profit Declines 41 YoY as Revenue Slips Board Declares Final Dividend Nuveen NMI Stock Analysis Climbs 065 Eyes on 1131 20260520 Viridian Therapeutics Prices Upsized 350M Concurrent Public Offerings Bond Market Signals Concerns as Warsh Takes Helm Traders Eye Shift from Easing to Tightening IBM Gains 27 Billion in Market Cap After Trumps 2 Billion Quantum Computing Push India Energy Investment Set to Reach 170 Billion by 2026 Driven by Solar Grid and Refining IEA West Bengal to Implement PM Vishwakarma Scheme to Support Artisans and Traditional Skills Morning Squawk Highlights Micron Milestone Dicks Earnings and Texas Political Shifts Microsoft Shares Feel the Heat Amid SaaSmaggedon Selloff in Cloud Software Sector OFS Q1 2026 Earnings Staggering EPS Beat of 475 Surprises Market PANL Q1 2026 Earnings EPS Beats Estimates Amid Broader Market Headwinds ADTX Q3 2025 Earnings Deep Losses and Lack of Revenue Continue as Stock Tumbles Over 45 IMMR Q3 2025 Earnings Strong EPS Beat Drives Positive Market Reaction UVV Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Slips Ennis Inc Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher Primerica PRI Q1 2026 Earnings EPS Surpasses Estimates by 77 Amid Mixed Market Reaction ZIM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions Dyadic International Inc DYAI Q1 2026 Earnings EPS Misses Estimates as PreRevenue Status Continues PetMed Express PETS Q1 2026 Earnings Massive EPS Miss Shocks Market Despite Positive Stock Reaction Recursion Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Pipeline Progress